Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited-Reference-Cited by-同舟云学术

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited

Published:2021-01 Issue:1 Volume:57 Page:106243
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Gautret Philippe,Lagier Jean-Christophe,Honoré Stéphane,Hoang Van Thuan,Colson Philippe,Raoult Didier

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference4 articles.

1. Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial;Dos Santos;Int J Antimicrob Agents.,2021

2. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial;Gautret;Int J Antimicrob Agents,2020

3. Raoult D. L’éthique du traitement contre l’éthique de la recherche [Available from https://www.lequotidiendumedecin.fr/specialites/infectiologie/lethique-du-traitement-contre-lethique-de-la-recherche-le-pr-didier-raoult-critique-les-derives-de]

4. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis;Lagier;Travel Med Infect Dis.,2020

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Covid-19's Current Development in Therapeutic and Diagnostic Techniques;Biosciences Biotechnology Research Asia;2023-12-31

2. Severeness of COVID-19 in patients with rheumatic diseases: A retrospective study from eastern China;2023-08-21

3. Potential drugs in COVID-19 management;Current Medicinal Chemistry;2023-07-17

4. Persistent Exhausted T-Cell Immunity after Severe COVID-19: 6-Month Evaluation in a Prospective Observational Study;Journal of Clinical Medicine;2023-05-18

5. The Potential of <i>Clerodendrum paniculatum</i> Leaves Fraction as a 3-Chymotrypsin-Like (3CL) Protease Inhibitor of SARS-CoV-2;Indonesian Journal of Chemistry;2023-05-05